Valentina E. Schneeberger

发表

ROR1 functions as a scaffold of cavin-1 and CAV1, sustaining caveolae and RTK-mediated survival signaling in lung cancer

D. Coppola, B. Hogan, M. Budzevich, 2016 .

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

C. Rudin, B. Teicher, N. Rekhtman, 2016, Clinical Cancer Research.

Target engagement imaging of PARP inhibitors in small-cell lung cancer

John T. Poirier, Charles M. Rudin, Wolfgang A. Weber, 2018, Nature Communications.

SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.

Yuan Ren, Eric B Haura, Domenico Coppola, 2014, Carcinogenesis.

Preclinical Modeling of KIF5B–RET Fusion Lung Adenocarcinoma

D. Coppola, Jie Wu, M. Budzevich, 2016, Molecular Cancer Therapeutics.

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.

C. Rudin, P. Massion, J. Sage, 2017, Cancer cell.

Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis

C. Rudin, J. Poirier, V. Allaj, 2016, PloS one.

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

D. Coppola, Yuan Ren, Jie Wu, 2015, Oncotarget.

Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2.

Jie Wu, S. Sebti, H. Lawrence, 2012, Cancer letters.

Novel Roles of the Protein Tyrosine Phosphatase SHP2 in Non-small Cell Lung Cancer

Valentina E. Schneeberger, 2014 .

SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.

D. Coppola, Yuan Ren, Jie Wu, 2014, Carcinogenesis.

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.

C. Rudin, P. Massion, J. Sage, 2017, Cancer cell.

Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2.

Jie Wu, S. Sebti, H. Lawrence, 2012, Cancer letters.